Skip to content

SCHEDULE 13D/AAccepted Jun 23, 5:06 PM ET

Chemomab Therapeutics Ltd. SCHEDULE 13D/A

OrbiMed Israel BioFund GP Limited Partnership

Accepted (ET)

5:06 PM

Jun 23, 2025

Filed

Jun 23, 2025

Documents

2

Size

27.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.